Platelet-rich plasma (PRP) is also known as plateletrich growth factors (GFs), platelet-rich fibrin (PRF) matrix, PRF, and platelet concentrate.
More recently, the interest in the application of PRP in dermatology; i.e., in tissue regeneration, wound healing, scar revision, skin rejuvenating effects, and alopecia, has increased [1, [6] [7] [8] [9] [10] [11] [12] [13] [14] .
Wounds have a proinflammatory biochemical environment that impairs healing in chronic ulcers. In addition, it is characterized by a high protease activity, which decreases the effective GF concentration. PRP is used as an interesting alternative treatment for recalcitrant wounds because it is a source of GFs and consequently has mitogenic, angiogenic, and chemotactic properties [12] .
In cosmetic dermatology, a study performed in vitro demonstrated that PRP can stimulate human dermal fibroblast proliferation and increase type I collagen synthesis [13] . Additionally, based on histological evidence, PRP injected in human deep dermis and immediate subdermis induces soft-tissue augmentation, activation of fibroblasts, and new collagen deposition, as well as new blood vessels and adipose tissue formation [14, 15] .
Another application of PRP is the improvement of burn scars, postsurgical scars, and acne scars [16] . According to the few articles available, PRP alone or in combination with other techniques seems to improve the quality of the skin and leads to an increase in collagen and elastic fibers.
In 2006, PRP has started to be considered a potential therapeutic tool for promoting hair growth and has been postulated as a new therapy for alopecia, in both androgenetic alopecia and alopecia areata. Several studies have been published that refer to the positive effect PRP has on androgenetic alopecia, although a recent meta-analysis suggested the lack of randomized controlled trials [17] . As stated by the authors, controlled clinical trials are considered the best way to provide scientific evidence for a treatment and avoid potential bias when assessing efficacy [18] .
Platelet Biology
All blood cells derive from a common pluripotent stem cell, which differentiates into different cell lines. Each of these cell series contains precursors that can divide and mature.
Platelets, also called thrombocytes, develop from the bone marrow. Platelets are nucleated, discoid cellular elements with different sizes and a density of approximately 2 μm in diameter, the smallest density of all blood cells. The physiological count of platelets circulating in the blood stream ranges from 150,000 to 400,000 platelets per μL.
Platelets contain several secretory granules that are crucial to platelet function. There are 3 types of granules: dense granules, o-granules, and lysosomes. In each platelet there are approximately 50-80 granules, the most abundant of the 3 types of granules.
Platelets are primarily responsible for the aggregation process. The main function is to contribute to homeostasis trough 3 processes: adhesion, activation, and aggregation. During a vascular lesion, platelets are activated, and their granules release factors that promote coagulation [19] .
Platelets were thought to have only hemostatic activity, although in recent years, scientific research and technology has provided a new perspective on platelets and their functions. Studies suggest that platelets contain an abundance of GFs and cytokines that can affect inflammation, angiogenesis, stem cell migration, and cell proliferation [20] .
PRP is a natural source of signaling molecules, and upon activation of platelets in PRP, the P-granules are degranulated and release the GFs and cytokines that will modify the pericellular microenvironment. Some of the most important GFs released by platelets in PRP include vascular endothelial GF, fibroblast GF (FGF), platelet-derived GF, epidermal GF, hepatocyte GF, insulin-like GF 1, 2 (IGF-1, IGF-2), matrix metalloproteinases 2, 9, and interleukin 8 [1, 21] .
Definition
PRP is a biological product defined as a portion of the plasma fraction of autologous blood with a platelet concentration above the baseline (before centrifugation) [22] . As such, PRP contains not only a high level of platelets but also the full complement of clotting factors, the latter typically remaining at their normal, physiologic levels [23] . It is enriched by a range of GFs, chemokines, cytokines, and other plasma proteins [4] .
The PRP is obtained from the blood of patients before centrifugation. After centrifugation and according to their different density gradients, the separation of blood components (red blood cells, PRP, and platelet-poor plasma [PPP]) follows.
In PRP, besides the higher concentration of platelets, other parameters need to be taken into account, such as the presence or absence of leucocytes and activation. This will define the type of PRP used in different pathologies.
There are several commercial devices available, which simplify the preparation of PRP. According to the manufacturers, PRP devices usually achieve a concentration of PRP 2-5 times the baseline concentration. Although one might think that a higher platelet count with a higher number of GFs would lead to better results, this has not been determined yet [20] . In addition, 1 study also suggests that a concentration of PRP 2.5 times above the baseline could have an inhibitory effect [24] .
Mechanism of Action in Alopecia
The GFs and the bioactive molecules present in PRP promote 4 main actions in the local environment of the administration, such as proliferation, migration, cell differentiation, and angiogenesis [22, [25] [26] [27] [28] . Various cytokines and GFs are involved in the regulation of hair morphogenesis and cycle hair growth [29] .
The dermal papilla (DP) cells produce GFs such as IGF-1, FGF-7, hepatocyte growth factor, and vascular endothelial growth factor that are responsible for maintaining the hair follicle in the anagen phase of the hair cycle. Therefore, a potential target would be to upregulate these GFs within the DP cells, which lengthen the anagen phase [30] .
According to a study performed by Akiyama et al. [31] , epidermal growth factor and transforming growth factor are involved in regulating the growth and differentiation of bulge cells, and platelet-derived growth factor may have related functions in the interactions between the bulge and the associated tissues, starting with follicle morphogenesis [27] .
Beside the GFs, the anagen phase is also activated by Wnt/β-catenin/T-cell factor lymphoid enhancer [32] . In the DP cells, the activation of Wnt will lead to an accumulation of β-catenin, which, in combination with the T-cell factor lymphoid enhancer, also acts as a co-activator of transcription and promotes proliferation, survival, and angiogenesis. The DP cells then initiate the differentiation and consequently the transition from the telogen to the anagen phase [25] . β-Catenin signaling is important in human follicle development and for the hair growth cycle.
Another pathway presented in DP is the activation of extracellular signal-regulated kinase (ERK) and protein kinase B (Akt) signaling that promotes cell survival and prevents apoptosis [6] .
The precise mechanism by which PRP promotes hair growth is not fully understood. To explore the possible mechanisms involved, Li et al.
[6] performed a well-designed study to investigate the effects of PRP on hair growth using in vitro and in vivo models. In the in vitro model, activated PRP was applied to human DP cells obtained from normal human scalp skin. The results demonstrated that PRP increased the proliferation of human DP cells by activating ERK and Akt signaling, leading to antiapoptotic effects. PRP also increased the β-catenin activity and FGF-7 expression in DP cells. Concerning the in vivo model, mice injected with activated PRP showed a faster telogen-to-anagen transition in comparison to the control group.
Recently, Gupta and Carviel [25] also proposed a mechanism for the action of PRP on the human follicles that includes the "elicitation of the Wnt/β-catenin, ERK, and Akt signaling pathways fostering cell survival, proliferation, and differentiation."
After GF binds with its correspondent GF receptor, the signaling necessary for its expression begins. The GF-GF receptor activates the expression of both Akt and ERK signaling. The activation of Akt will inhibit 2 pathways through phosphorylation: (1) the glycogen synthase kinase-3β that promotes degradation of β-catenin, and (2) Bcl-2-associated death promoter, which is responsible for inducing apoptosis. As stated by the authors, PRP might increase vascularization, prevent apoptosis, and prolong the duration of the anagen phase [27] .
The main functions of the GFs presented in the PRP are detailed in Table 1 .
Devices to Obtain PRP
Currently, there is a great discussion and no consensus regarding PRP preparation. PRP is prepared through a process known as differential centrifugation, in which acceleration force is adjusted to sediment certain cellular constituents based on different specific gravity [33] .
Regarding the preparation of PRP, there are 2 techniques: 1. Open technique: the product is exposed to the environment of the working area and comes in contact with different materials that should be used for their production, such as pipettes or product-collection tubes. In the blood processing to obtain PRP with the open technique, it should be guaranteed that the product is not contaminated during microbiological handling. 21 ment and application) in which the product is not exposed to the environment (recommended). Several CE medical devices are available for the production of autologous PRP. Most of them are included in one of the following 3 types of devices: 1. The blood is obtained with a tube that contains an anticoagulant, and this tube can be used for any type of centrifuge. 2. Medical devices with which the blood is collected into a tube that already contains an anticoagulant; the centrifugation can then be made in any type of centrifuge. 3. Medical devices with which the blood is collected into a syringe previously filled with an anticoagulant; usually, the blood is transferred into a secondary device whose shape imposes the use of the centrifuge supplied by the same manufacturer [34] . The preparation of PRP depends on the type of device chosen and should be done according to the manufacturer's instructions ( Table 2 ) .
As described in Table 2 , there are different PRP systems that facilitate the preparation of PRP in a reproducible manner. All operate on a small volume of drawn blood and on the principle of centrifugation.
Briefly, the procedure requires the use of relatively small volumes of blood. The PRP is obtained from the blood of patients before centrifugation. The whole blood is obtained by venipuncture in anticoagulated tubes (usually with acid citrate dextrose or sodium citrate solution). The blood is then centrifuged with single-or a doublespin centrifugation, depending on the device. The settings of the centrifuge established to obtain PRP at an adjustable concentration are defined by the manufacturer and cannot be changed by the physician.
After centrifugation, the tube shows 3 basic layers: at the bottom of the tube, there are red blood cells with leukocytes deposited immediately above; the middle layer corresponds to the PRP, and at the top, there is the PPP ( Fig. 1 ) . The PPP is removed, and PRP is obtained. Platelets can be activated before application of the PRP, although there is no consensus on whether or not platelets must be previously activated before their application and with which agonist [35] .
Thrombin and calcium chloride, which are aggregation inducers, are used with the aim to activate platelets and stimulate degranulation, causing the release of the GFs [36] .
Some authors activate platelets, whereas others apply platelets without previously activating them, arguing that better results are obtained. Recent studies found that the use of such aggregators is not necessary because at the time of administration, the platelets are automatically released and ready to exert their function.
Even though most devices aim to obtain the best PRP, the systems differ extensively in their ability to collect and concentrate platelets depending on the method and time of its centrifugation. As a result, suspensions of different concentrations of platelets and leucocytes are obtained. It is difficult to assess which kit for PRP preparation is better and which is worse [33] . In addition, each preparation may produce different types of PRP with different applications. There is no consensus about the number of centrifugations required, nor on their speed duration.
There is intensive ongoing debate regarding the ideal volume of PRP to administer, the frequency of application, the exact site of administration of PRP, and which technique/preparation system of manufacture to use. 
Classification
Several authors have tried to characterize and classify the numerous techniques available on the market in terms of preparation (centrifugation speed and use of anticoagulant), content (platelets, leucocytes, and GFs), and applications [36] .
Although the literature about PRPs developed with all these contradictions, the need for a standardized terminology is of great importance [36, 37] . Thus, some classifications have been proposed to achieve a consensus terminology in the field of platelet concentrates [37] [38] [39] [40] [41] [42] .
Characterizing the type of PRP used (as a pure PRP in our study) will lead to a better understanding of PRP, and data available will be easier to sort and interpret. Furthermore, this terminology would serve as a basis for further research on the topic.
In 2009, Dohan Ehrenfest et al. [38] proposed a classification of 4 main families of preparations following 2 principle parameters: presence or absence of a cell content (such as leucocytes) and the fibrin architecture: 1. Pure PRP or leucocyte-poor PRP: the preparation obtained is without leucocytes and shows a low-density fibrin network after activation. 2. Leucocyte and PRP: the preparations contain leucocytes and show a low-density fibrin network after activation. 3. Pure PRF or leucocyte-poor PRF: preparations are without leucocytes and with a high-density fibrin network. Unlike pure PRP or PRP containing leukocytes, Density, g/mL Fig. 1 . After centrifugation, the blood components (red blood cells , leukocytes, and platelets) are separated from the plasma due to their different densities. The platelets have the lowest density. Adapted from Dohan Ehrenfest et al. [38] .
